The term “synucleinopathies” defines a group of human neurodegenerative disorders characterized by the presence of amyloidogenic α-synuclein (α-syn) inclusions that can occur in neurons and glia cells of the central and peripheral nervous system. Here, SNCA is linked to synucleinopathy.